BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Princeton Bancorp
BPRN
$217M
| $6.15K | ﹤0.01% |
224
+223
| +22,300% | +$6.12K |
|
|
TRVN
2977
DELISTED
Trevena, Inc.
TRVN
| $5.99K | ﹤0.01% |
23
-3
| -12% | -$782 |
|
2978
VirnetX
VHC
$74.6M
| $5.93K | ﹤0.01% |
254
-23,098
| -99% | -$540K |
|
2979
Neuronetics
STIM
$228M
| $5.92K | ﹤0.01% |
1,844
-6,404
| -78% | -$20.6K |
|
|
AMPE
2980
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $5.86K | ﹤0.01% |
116
+59
| +104% | +$2.98K |
|
|
EMKR
2981
DELISTED
Emcore Corp
EMKR
| $5.82K | ﹤0.01% |
190
-2,472
| -93% | -$75.7K |
|
2982
Vanguard Small-Cap ETF
VB
$66.7B
| $5.81K | ﹤0.01% |
33
-23
| -41% | -$4.05K |
|
2983
American Realty Investors
ARL
$263M
| $5.79K | ﹤0.01% |
408
+391
| +2,300% | +$5.55K |
|
|
USX
2984
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $5.79K | ﹤0.01% |
2,159
-8,340
| -79% | -$22.4K |
|
2985
Mayville Engineering Co
MEC
$293M
| $5.63K | ﹤0.01% |
727
-767
| -51% | -$5.94K |
|
2986
iShares MSCI USA Momentum Factor ETF
MTUM
$18.9B
| $5.59K | ﹤0.01% |
41
+6
| +17% | +$818 |
|
|
BCYC
2987
Bicycle Therapeutics
BCYC
$485M
| $5.59K | ﹤0.01% |
+333
| New | +$5.59K |
|
|
TARO
2988
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $5.57K | ﹤0.01% |
154
+51
| +50% | +$1.84K |
|
2989
Lazydays
GORV
$8.29M
| $5.49K | ﹤0.01% |
16
-96
| -86% | -$32.9K |
|
|
SRT
2990
DELISTED
Startek Inc.
SRT
| $5.43K | ﹤0.01% |
1,877
-18,953
| -91% | -$54.8K |
|
2991
Willis Lease Finance
WLFC
$1.13B
| $5.4K | ﹤0.01% |
144
-1,115
| -89% | -$41.8K |
|
|
FLNT
2992
Fluent
FLNT
$48.1M
| $5.33K | ﹤0.01% |
747
-8,599
| -92% | -$61.4K |
|
2993
Harrow
HROW
$1.44B
| $5.26K | ﹤0.01% |
722
-102
| -12% | -$743 |
|
2994
LCNB Corp
LCNB
$227M
| $5.13K | ﹤0.01% |
+343
| New | +$5.13K |
|
2995
iShares US Infrastructure ETF
IFRA
$2.97B
| $5.11K | ﹤0.01% |
150
-568
| -79% | -$19.3K |
|
|
SEEL
2996
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $5.1K | ﹤0.01% |
2
| – | – |
|
2997
PAVmed
PAVM
$9.29M
| $5.07K | ﹤0.01% |
362
-40,554
| -99% | -$568K |
|
2998
Cadiz
CDZI
$295M
| $5.07K | ﹤0.01% |
2,174
+226
| +12% | +$527 |
|
|
VAPO
2999
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.72K | ﹤0.01% |
233
-18
| -7% | -$365 |
|
|
BELFB
3000
Bel Fuse Class B
BELFB
$1.84B
| $4.67K | ﹤0.01% |
300
+263
| +711% | +$4.09K |
|